Background Antimicrobial resistance (AMR) is a global threat for people with chronic lung infection; however, international AMR epidemiology in bronchiectasis and cystic fibrosis (CF) is poorly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results